使用Player FM应用程序离线!
All Eyes on ExPEC: A Major Driver of Invasive Disease and Antimicrobial Resistance
Manage episode 344563822 series 2884624
In this episode, Lilian Abbo, MD, FIDSA; Julie Ann Justo, PharmD, MS; and David van Duin, MD, PhD, FIDSA, FAST, discuss key concepts about extraintestinal pathogenic Escherichia coli, including:
- Diverse strains and virulence factors associated with invasive disease
- Antimicrobial resistance profiles seen in clinical practice
- Various disease manifestations
- Prevalence and burden of invasive infections
- Populations at risk
- Risk factors for multidrug-resistant strains
- Emerging vaccine technologies
- Active clinical trials
- Benefits of vaccines and the challenges associated with development
- Importance of antimicrobial stewardship and potential role of vaccines to reduce antimicrobial resistance
Program Director:
Lilian Abbo, MD, FIDSA
Associate Chief Medical Officer in Infectious Diseases
Jackson Health System
Professor of Infectious Diseases
Department of Medicine & Miami Transplant Institute
University of Miami Miller School of Medicine
Miami, Florida
Faculty:
Julie Ann Justo, PharmD, MS
Clinical Associate Professor
Department of Clinical Pharmacy and Outcomes Sciences
University of South Carolina College of Pharmacy
Infectious Diseases Clinical Pharmacy Specialist
Department of Pharmacy
Prisma Health Richland Hospital
Columbia, South Carolina
David Van Duin, MD, PhD, FIDSA, FAST
Professor of Medicine
Director, Immunocompromised Host Infectious Diseases Program
Division of Infectious Diseases
University of North Carolina
Chapel Hill, North Carolina
Content based on a CME program supported by an educational grant from Janssen Therapeutics.
Follow along with a downloadable slideset at:
https://bit.ly/3eG29Bn
Link to full program:
https://bit.ly/3eFHfCl
379集单集
Manage episode 344563822 series 2884624
In this episode, Lilian Abbo, MD, FIDSA; Julie Ann Justo, PharmD, MS; and David van Duin, MD, PhD, FIDSA, FAST, discuss key concepts about extraintestinal pathogenic Escherichia coli, including:
- Diverse strains and virulence factors associated with invasive disease
- Antimicrobial resistance profiles seen in clinical practice
- Various disease manifestations
- Prevalence and burden of invasive infections
- Populations at risk
- Risk factors for multidrug-resistant strains
- Emerging vaccine technologies
- Active clinical trials
- Benefits of vaccines and the challenges associated with development
- Importance of antimicrobial stewardship and potential role of vaccines to reduce antimicrobial resistance
Program Director:
Lilian Abbo, MD, FIDSA
Associate Chief Medical Officer in Infectious Diseases
Jackson Health System
Professor of Infectious Diseases
Department of Medicine & Miami Transplant Institute
University of Miami Miller School of Medicine
Miami, Florida
Faculty:
Julie Ann Justo, PharmD, MS
Clinical Associate Professor
Department of Clinical Pharmacy and Outcomes Sciences
University of South Carolina College of Pharmacy
Infectious Diseases Clinical Pharmacy Specialist
Department of Pharmacy
Prisma Health Richland Hospital
Columbia, South Carolina
David Van Duin, MD, PhD, FIDSA, FAST
Professor of Medicine
Director, Immunocompromised Host Infectious Diseases Program
Division of Infectious Diseases
University of North Carolina
Chapel Hill, North Carolina
Content based on a CME program supported by an educational grant from Janssen Therapeutics.
Follow along with a downloadable slideset at:
https://bit.ly/3eG29Bn
Link to full program:
https://bit.ly/3eFHfCl
379集单集
すべてのエピソード
×欢迎使用Player FM
Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。